OncoMed Pharmaceuticals, Inc. was a public American pharmaceutical development company headquartered in Redwood City, California.[2] The company was founded in August 2004 by two University of Michigan investigators, Michael Clarke and Max S. Wicha.[2][4] As of 2013[update], the company had 83 employees.[3] OncoMed's drug discovery work focuses on developing "targeted antibodies against cancer stem cells".[3] The cancer stem cell technologies on which OncoMed depends are licensed from the University of Michigan where they were developed by the founders of the company.[4] OncoMed went public in 2013 and was listed on NASDAQ under the stock symbol OMED.[3][4] In April 2019 the company was acquired by Mereo BioPharma and delisted from the Nasdaq.
^"Archived copy". Archived from the original on 2017-01-06. Retrieved 2017-01-05.{{cite web}}: CS1 maint: archived copy as title (link)
^ abcCite error: The named reference leuty2007 was invoked but never defined (see the help page).
^ abcdCite error: The named reference timmerman2013 was invoked but never defined (see the help page).
^ abcdCite error: The named reference uofmhs2013pr was invoked but never defined (see the help page).
^Cite error: The named reference leuty2014 was invoked but never defined (see the help page).
holds that OncoMed is the best positioned of the three companies focused on the cancer stem cell area. As of January 2017[update], Oncomed had seven clinical-stage...
and OncoMed Pharmaceuticals joined a cancer stem cell therapeutic development agreement with demcizumab and five other biologics from OncoMed's pipeline...
and is currently undergoing phase 2 trials. Demcizumab was developed by OncoMed Pharmaceuticals in collaboration with Celgene. Demcizumab blocks Delta-like...
treatment of cancer. This drug was developed by OncoMed Pharmaceuticals Inc. in partnership with Bayer. OncoMed was awarded a patent in 2016, which is set...
by SAP AG. Its Redwood City office was later occupied by ApniCure and OncoMed Pharmaceuticals Inc. The first issue of NeXTWORLD magazine was printed...
antibody designed for the treatment of cancer. This drug was developed by OncoMed Pharmaceuticals. Statement On A Nonproprietary Name Adopted By The USAN...
abstracted and indexed in PubMed, Scopus, and others. The journal has a 2021 impact factor of 4.345. Press, Dove. "OncoTargets and Therapy - Dove Press...
antibody designed for the treatment of cancer. This drug was developed by OncoMed Pharmaceuticals. World Health Organization (2016). "International Nonproprietary...
cease sterile compounding after unspecified violations were found, and OncoMed Pharmaceutical Services was ordered to close its Waltham facility after...
OncoDNA is a Belgium-based company founded in December 2012 focusing on precision medicine in oncology. The company aims to provide cancer molecular profiling...
corporation owns 50% of two subsidiaries, Oncotec GmbH in Dessau Germany and oncomed manufacturing a.s. in the Czech Republic city of Brno, for the production...
laherparepvec was created and initially developed by BioVex, Inc. under the brand OncoVEXGM-CSF. Development was continued by Amgen, which acquired BioVex in 2011...
Codexis, Genomic Health, Guardant Health, Gynesonics, Minerva Surgical, OncoMed, Stem Cell Theranostics, and Teva. San Francisco Bay Area portal Bair Island...
gov. FDA. Retrieved 22 October 2023. "Xromi- hydroxyurea solution". DailyMed. 8 April 2024. Retrieved 18 May 2024. "Hydroxyurea". The American Society...
Abbott Vascular Paul Hastings, president and chief executive officer, OncoMed Pharmaceuticals; Terry Hermiston, Ph.D., vice president, U.S. Biologics...
and Midwifery Studies Nutrition Discovery Oman Journal of Ophthalmology Onco Fertility Journal Oncology Journal of India Oncology, Gastroenterology and...
Research and Reviews Nutrition and Dietary Supplements Oncolytic Virotherapy OncoTargets and Therapy Open Access Animal Physiology† Open Access Bioinformatics†...
Retrieved 22 October 2023. "Lansoprazole capsule, delayed release pellets". DailyMed. U.S. National Library of Medicine. 11 October 2016. Retrieved 31 December...
Society 2023 Recognized as one of the 100 Influential Women in Oncology by OncoDaily Bertagnolli is married and has two sons. After a routine mammogram,...
GRCh38: Ensembl release 89: ENSG00000227036 – Ensembl, May 2017 "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National...
metaplasia (breast gland only). Oncocytic cell Derived from the Greek root onco-, which means mass, bulk. Hurthle cell carcinoma, a variant of follicular...
GRCh38: Ensembl release 89: ENSG00000214548 – Ensembl, May 2017 "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National...
May 2022. Park, Andrea (1 October 2021). "Sophia Genetics teams up with OncoDNA to automate tumor profiling". Fierce Biotech. Retrieved 25 February 2022...
Nepal) Oral and Maxillofacial Surgery Plastic and Reconstructive Surgery Onco Surgery Nephrology: Eight hemodialysis machines for routine and emergency...
Global Information